Research
Research outputs for the last seven years are shown below. To see earlier years visit ORCID
Open access indicates that an output is open access.
Year | Output |
---|---|
2022 |
Open access
13
|
2022 |
Open access
|
2022 |
Open access
|
2021 |
Open access
2
2
2
|
2021 |
Open access
7
4
8
|
2020 |
Open access
14
12
5
|
2019 |
Open access
21
21
5
|
2019 |
16
19
2
|
2019 |
3
2
|
2019 |
Open access
10
11
20
|
2018 |
18
17
5
|
2018 |
Open access
36
34
3
|
2016 |
Open access
22
6
|
2016 |
Open access
187
183
11
|
2015 |
71
65
18
|
2015 |
25
26
1
|
2014 |
Open access
205
195
26
|
2014 |
22
23
25
|
2014 |
Open access
18
2
|
2014 |
Open access
8
9
1
|
2014 |
Open access
21
18
1
|
2014 |
6
6
1
|
2014 |
13
12
3
|
2010 |
Open access
26
27
|
External engagement & recognition
Organisation | Country |
---|---|
Amgen Inc | UNITED STATES |
Australian National University | AUSTRALIA |
Baylor College of Medicine | UNITED STATES |
Flinders Medical Centre | AUSTRALIA |
Flinders University | AUSTRALIA |
Houston Methodist Hospital | UNITED STATES |
Institute of Medical and Veterinary Science | AUSTRALIA |
Lipotek Pty Ltd | AUSTRALIA |
Peter MacCallum Cancer Centre | AUSTRALIA |
QIMR Berghofer Medical Research Institute | AUSTRALIA |
Queensland Institute of Medical Research | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Royal Darwin Hospital | AUSTRALIA |
SA Pathology | AUSTRALIA |
South Australian Health and Medical Research Institute (SAHMRI) | AUSTRALIA |
Sydney Children's Hospital | AUSTRALIA |
University of Adelaide | AUSTRALIA |
University of Melbourne | AUSTRALIA |
University of New South Wales | AUSTRALIA |
University of North Carolina at Chapel Hill | UNITED STATES |
University of Queensland | AUSTRALIA |
University of South Australia | AUSTRALIA |
University of Texas | UNITED STATES |
Women and Children's Health Research Institute | CANADA |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
Finding out how well chimeric antigen receptor (CAR)-T cells kill brain tumour cells | Current |
Identifying optimal immunotherapy combinations for the treatment of brain tumours | Current |